Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178


Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire.

Noël E, Dussol B, Lacombe D, Bedreddine N, Fouilhoux A, Ronco P, Genevaz D, Bekri S, Hagège A, Dupuis-Siméon F, Derrien Ansquer V, Germain DP, Lidove O.

Orphanet J Rare Dis. 2019 Dec 4;14(1):284. doi: 10.1186/s13023-019-1254-7.


Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.

Seguier J, Jouve E, Bobot M, Whalen E, Dussol B, Gentile S, Burtey S, Halfon P, Retornaz F, Chaussabel D, Chiche L, Jourde-Chiche N.

Rheumatology (Oxford). 2019 Nov 27. pii: kez541. doi: 10.1093/rheumatology/kez541. [Epub ahead of print]


The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Bennis Y, Cluet Y, Titeca-Beauport D, El Esper N, Ureña P, Bodeau S, Combe C, Dussol B, Fouque D, Choukroun G, Liabeuf S.

Toxins (Basel). 2019 May 17;11(5). pii: E279. doi: 10.3390/toxins11050279.


Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, Pontoizeau C, Cochat P, Bataille P, Bridoux F, Brignon P, Choquenet C, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Frimat M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

BJU Int. 2019 Nov;124(5):849-861. doi: 10.1111/bju.14721. Epub 2019 Mar 25.


An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).

Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators.

Kidney Int. 2018 Dec;94(6):1217-1226. doi: 10.1016/j.kint.2018.07.021. Epub 2018 Oct 29.


Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.

Mauhin W, Lidove O, Amelin D, Lamari F, Caillaud C, Mingozzi F, Dzangué-Tchoupou G, Arouche-Delaperche L, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Froissart R, Lacombe D, Ziza JM, Hachulla E, Benveniste O.

Orphanet J Rare Dis. 2018 Jul 31;13(1):127. doi: 10.1186/s13023-018-0877-4.


Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France.

Mouelhi Y, Jouve E, Alessandrini M, Pedinielli N, Moal V, Meurette A, Cassuto E, Mourad G, Durrbach A, Dussol B, Gentile S.

BMC Nephrol. 2018 Apr 27;19(1):99. doi: 10.1186/s12882-018-0893-6.


Cerebral pseudotumor as the first manifestation of POEMS syndrome: A case report.

Benyamine A, Delteil C, Macagno N, Belenotti P, Dussol B, Girard N, Weiller PJ, Granel B, Daniel L.

Clin Neuropathol. 2018 Mar/Apr;37 (2018)(2):87-90. doi: 10.5414/NP301068. No abstract available.


Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.

Paul P, Picard C, Sampol E, Lyonnet L, Di Cristofaro J, Paul-Delvaux L, Lano G, Nicolino-Brunet C, Ravis E, Collart F, Dignat-George F, Dussol B, Sabatier F, Mouly-Bandini A.

Circulation. 2018 Mar 6;137(10):1049-1059. doi: 10.1161/CIRCULATIONAHA.117.030435. Epub 2017 Nov 2.


Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.


[Uro- and nephrotoxic effects of drugs of abuse: Literature review and pharmaco-epidemiological survey in France and in the Marseille area].

Gully M, Frauger É, Spadari M, Pochard L, Pauly V, Romain F, Gondouin B, Sallée M, Moussi-Frances J, Burtey S, Dussol B, Daniel L, Micallef J, Jourde-Chiche N.

Nephrol Ther. 2017 Nov;13(6):429-438. doi: 10.1016/j.nephro.2017.01.024. Epub 2017 Sep 27. Review. French.


Internet and social network users' profiles in Renal Transplant Recipients in France.

Mouelhi Y, Alessandrini M, Pauly V, Dussol B, Gentile S.

BMC Nephrol. 2017 Aug 3;18(1):259. doi: 10.1186/s12882-017-0670-y.


Peripheral nerve involvement in Fabry's disease: Which investigations? A case series and review of the literature.

Franques J, Sahuc P, Dussol B, Penaranda G, Swiader L, Froissart R, Attarian S, Stavris C, Chiche L, Pouget J.

Rev Neurol (Paris). 2017 Dec;173(10):650-657. doi: 10.1016/j.neurol.2017.05.007. Epub 2017 Jun 1. Review.


Analysis of Anelloviridae sequences characterized from serial human and animal biological samples.

Bédarida S, Dussol B, Signoli M, Biagini P.

Infect Genet Evol. 2017 Sep;53:89-93. doi: 10.1016/j.meegid.2017.05.017. Epub 2017 May 20.


Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.

Jourde-Chiche N, Whalen E, Gondouin B, Speake C, Gersuk V, Dussol B, Burtey S, Pascual V, Chaussabel D, Chiche L.

Rheumatology (Oxford). 2017 Mar 1;56(3):477-487. doi: 10.1093/rheumatology/kew439.


[Beware, polyarteritis nodosa still exists in nephrology!]

Perrin J, Carvelli J, Gondouin B, Daniel L, Fraisse M, Gaudon C, Bouzana F, Vacher-Coponat H, Moussi-Francès J, Dussol B, Jourde-Chiche N.

Nephrol Ther. 2016 Nov;12(6):463-467. doi: 10.1016/j.nephro.2016.03.007. Epub 2016 Sep 24. French.


Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study.

Legendre M, Devilliers H, Perard L, Groh M, Nefti H, Dussol B, Trad S, Touré F, Abad S, Boffa JJ, Frimat L, Torner S, Seidowsky A, Massy ZA, Saadoun D, Rieu V, Schoindre Y, Heron E, Frouget T, Lionet A, Glowacki F, Arnaud L, Mousson C, Besancenot JF, Rebibou JM, Bielefeld P.

Medicine (Baltimore). 2016 Jun;95(26):e3964. doi: 10.1097/MD.0000000000003964.


Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group.

J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.


Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N.

Medicine (Baltimore). 2016 May;95(22):e3748. doi: 10.1097/MD.0000000000003748.


Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.

Retrovirology. 2016 May 9;13(1):35. No abstract available.


Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.

Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I.

Retrovirology. 2016 Apr 1;13:21. doi: 10.1186/s12977-016-0251-3. Erratum in: Retrovirology. 2016;13(1):35.


Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.

Laforet M, Jourde-Chiche N, Haddad F, Sallee M, Stoppa AM, Brunet P, Dussol B, Burtey S, Gondouin B.

Blood Cancer J. 2016 Mar 25;6:e409. doi: 10.1038/bcj.2016.17. No abstract available.


Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study.

Sahuc P, Chiche L, Dussol B, Pouget J, Franques J.

Ther Clin Risk Manag. 2016 Feb 2;12:135-8. doi: 10.2147/TCRM.S99241. eCollection 2016.


Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.

Decourt A, Gondouin B, Delaroziere JC, Brunet P, Sallée M, Burtey S, Dussol B, Ivanov V, Costello R, Couchoud C, Jourde-Chiche N.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41. doi: 10.2215/CJN.06290615. Epub 2016 Jan 4.


Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease.

Bobot M, Ghez C, Gondouin B, Sallée M, Fournier PE, Burtey S, Legris T, Dussol B, Berland Y, Souteyrand P, Tessonnier L, Cammilleri S, Jourde-Chiche N.

Clin Microbiol Infect. 2016 Jan;22(1):71-77. doi: 10.1016/j.cmi.2015.09.024. Epub 2015 Oct 8.


Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.

Gondouin B, Jourde-Chiche N, Sallee M, Dou L, Cerini C, Loundou A, Morange S, Berland Y, Burtey S, Brunet P, Guieu R, Dussol B.

Nephron. 2015;131(3):167-74. doi: 10.1159/000441091. Epub 2015 Oct 2.


Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: a prospective observational study.

Joly D, Choukroun G, Combe C, Dussol B, Fauvel JP, Halimi JM, Quéré S, Fiquet B.

Diabetes Res Clin Pract. 2015 Apr;108(1):120-7. doi: 10.1016/j.diabres.2015.01.029. Epub 2015 Feb 12.


CKD and Its Risk Factors among Patients with Cystinuria.

Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Bataille P, Bridoux F, Brignon P, Choquenet C, Cochat P, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Noël C, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M; French Cystinuria Group.

Clin J Am Soc Nephrol. 2015 May 7;10(5):842-51. doi: 10.2215/CJN.06680714. Epub 2015 Feb 25.


[Comparison of two national quality of life surveys for patients with end stage renal disease between 2005-2007 and 2011: indicators slightly decreased].

Beauger D, Gentile S, Jacquelinet C, Dussol B, Briançon S.

Nephrol Ther. 2015 Apr;11(2):88-96. doi: 10.1016/j.nephro.2014.10.003. Epub 2014 Nov 4. French.


The cardiovascular effect of the uremic solute indole-3 acetic acid.

Dou L, Sallée M, Cerini C, Poitevin S, Gondouin B, Jourde-Chiche N, Fallague K, Brunet P, Calaf R, Dussol B, Mallet B, Dignat-George F, Burtey S.

J Am Soc Nephrol. 2015 Apr;26(4):876-87. doi: 10.1681/ASN.2013121283. Epub 2014 Aug 21.


[Acid-base homeostasis: metabolic acidosis and metabolic alkalosis].

Dussol B.

Nephrol Ther. 2014 Jul;10(4):246-57. doi: 10.1016/j.nephro.2014.05.004. Epub 2014 Jun 30. French.


[Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France].

Jourde-Chiche N, Chiche L, Mancini J, Daniel L, Bardin N, Burtey S, Gondouin B, Dussol B, Harlé JR, Hamidou M, Meulders Q, Daugas E; Groupe Coopératif sur le Lupus Rénal.

Nephrol Ther. 2014 Jun;10(3):170-6. doi: 10.1016/j.nephro.2013.11.006. Epub 2014 Apr 3. French.


Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols.

Legris T, Picard C, Moal V, Burtey S, Loundou A, Purgus R, Dussol B, Berland Y, Vacher-Coponat H.

Ann Transplant. 2013 Nov 15;18:622-34. doi: 10.12659/AOT.889536.


Generalized calcinosis in systemic sclerosis.

Daumas A, Rossi P, Ariey-Bonnet D, Bernard F, Dussol B, Berbis P, Granel B.

QJM. 2014 Mar;107(3):219-21. doi: 10.1093/qjmed/hct195. Epub 2013 Sep 23. No abstract available.


Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients.

Beauger D, Gentile S, Jouve E, Dussol B, Jacquelinet C, Briançon S.

Health Qual Life Outcomes. 2013 Aug 30;11:148. doi: 10.1186/1477-7525-11-148.


Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France.

Gentile S, Beauger D, Speyer E, Jouve E, Dussol B, Jacquelinet C, Briançon S.

Health Qual Life Outcomes. 2013 May 30;11:88. doi: 10.1186/1477-7525-11-88.


Infection with hepatitis E virus in kidney transplant recipients in southeastern France.

Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gérolami R, Berland Y, Colson P.

J Med Virol. 2013 Mar;85(3):462-71. doi: 10.1002/jmv.23469. Epub 2012 Dec 12.


Is renal allograft dysfunction a risk factor for severe infection in kidney transplant recipients?

Mourad G, Dussol B, Daugas E, Joly D, Juillard L, Henri P, Stroumza P, Touam M; ANTICIPE Study Scientific Board.

Transplant Proc. 2012 Nov;44(9):2821-3. doi: 10.1016/j.transproceed.2012.09.088.


[Prepare: cross-sectional study on management of chronic kidney disease by nephrologists before dialysis in France].

Daugas E, Dussol B, Henri P, Joly D, Juillard L, Michaut P, Mourad G, Stroumza P, Touam M.

Nephrol Ther. 2012 Nov;8(6):439-50. doi: 10.1016/j.nephro.2012.06.003. Epub 2012 Sep 28. French.


Comparative safety and efficiency of five percutaneous kidney biopsy approaches of native kidneys: a multicenter study.

Bataille S, Jourde N, Daniel L, Mondain JR, Faure M, Gobert P, Alcheikh-Hassan Z, Lankester M, Giaime P, Gaudart J, Dussol B, Berland Y, Burtey S.

Am J Nephrol. 2012;35(5):387-93. doi: 10.1159/000337932. Epub 2012 Apr 13.


Vancomycin-induced Henoch-Schönlein purpura: a case report.

Bataille S, Daumas A, Tasei AM, Jourde-Chiche N, Dussol B, Burtey S, Taugourdeau S, Berland Y, Chiche L.

J Med Case Rep. 2012 Apr 10;6:106. doi: 10.1186/1752-1947-6-106.


Acute tubulointerstitial nephritis complicating Legionnaires' disease: a case report.

Daumas A, El-Mekaoui F, Bataille S, Daniel L, Caporossi JM, Fournier PE, Burtey S, Dussol B, Berland Y, Jourde-Chiche N.

J Med Case Rep. 2012 Apr 4;6:100. doi: 10.1186/1752-1947-6-100.


Clinical features and outcomes of ANCA-associated renal vasculitis.

Seck SM, Dussol B, Brunet P, Burtey S.

Saudi J Kidney Dis Transpl. 2012 Mar;23(2):301-5.


Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits.

Bataille S, Kaplanski G, Boucraut J, Halfon P, Camus C, Daniel L, Burtey S, Berland Y, Dussol B.

Am J Nephrol. 2012;35(2):134-40. doi: 10.1159/000335375. Epub 2012 Jan 13.


A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease.

Dussol B, Moussi-Frances J, Morange S, Somma-Delpero C, Mundler O, Berland Y.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):32-7. doi: 10.1111/j.1751-7176.2011.00564.x. Epub 2011 Dec 9.


A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.

Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.

Transplantation. 2012 Feb 27;93(4):437-43. doi: 10.1097/TP.0b013e31824215b7.


Correction of postkidney transplant anemia reduces progression of allograft nephropathy.

Choukroun G, Kamar N, Dussol B, Etienne I, Cassuto-Viguier E, Toupance O, Glowacki F, Moulin B, Lebranchu Y, Touchard G, Jaureguy M, Pallet N, Le Meur Y, Rostaing L, Martinez F; CAPRIT study Investigators.

J Am Soc Nephrol. 2012 Feb;23(2):360-8. doi: 10.1681/ASN.2011060546. Epub 2011 Dec 22.


Evolution of Anelloviridae strains distribution in serial blood and biopsy samples from a renal transplant patient.

Biagini P, Bédarida S, Dussol B, Daniel L, Berland Y, de Micco P.

J Med Virol. 2012 Jan;84(1):96-8. doi: 10.1002/jmv.22259. Epub 2011 Nov 3.


[Uric acid nephrolithiasis].

Dussol B.

Rev Prat. 2011 Mar;61(3):389-92. French.


Supplemental Content

Loading ...
Support Center